Friday, 10 June 2016

Impact of the DoH Commissioning for Quality and Innovation incentive on the success of venous thromboembolism risk assessment

"We achieved 95% RA [Risk Assessment] compliance which has favourably impacted on our daily practice and improved the quality of the clinical care."
The impact of the DoH Commissioning for Quality and Innovation incentive on the success of venous thromboembolism risk assessment in hospitalised patients. 
A Shlebak, P Sandhu, V Ali, G Jones, C Baker
Journal of the Royal Society of Medicine Open June 2016 vol. 7 no. 6 2054270416632702

Read more here.


No comments:

Post a Comment